Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / new to the street announces its four corporate inter mwn benzinga


SWISF - New to The Street Announces its Four Corporate Interviews Episode 543 Airing on the Fox Business Network Monday January 8 2024 at 10:30 PM PT | Benzinga

  • NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a nationally broadcasted TV show, announces episode 543, airing on the Fox Business Network, Monday, January 8, 2024, at 10:30 PM PT.

    New to The Street's 543rd TV episode line-up features the following four (4) Corporate interviews:

    1). Biopharmaceutical – Acurx Pharmaceuticals, Inc.'s (NASDAQ:ACXP) () interview with David Luci, President/CEO.

    2). "Game Changers Segment" interview with Dr. Navjit Dhaliwal, CEO, IAGON (CRYPTO: IAG) ()

    3). GOLD – Glint Pay's interview with Jason Cozens, CEO.

    4). "Sekur Privacy & Sekur Security – Weekly Hack" segment with internet privacy expert Mr. Alain Ghiai, CEO, Sekur Private Data, Ltd. (OTCQB:SWISF) (CSE:SKUR) (FRA: GDT0) (Sekur®).

    Episode 543

    New to The Street's TV Host Jane King from the Nasdaq MarketSite Studio talks with David Luci, the President/CEO of Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) (). As a clinical-stage biopharmaceutical business, ACXP is developing a new class of antibiotics for life-threatening bacterial infections. David updates viewers on the Company's FDA  Phase 2 clinical trial on the Ibezapolstat drug, a treatment for patients with Clostridioides difficile Infections (CDI). Based on positive data from Phase 2a and Phase 2b, management is now going forward with the FDA Phase 3. The Company compared its top-line data with the currently used standard-of-care drugs in the marketplace, and Ibezapolstat has impressive positive results. Phases 2a and 2b confirmed that the drug had success in 25 out of 26 patients, approximately 96% success with no reinfections. Competitor drugs have been used for decades to treat CDI, but the reinfection rates are very high. ACXP's Ibezapolstat study results have shown to combat reinfections effectively. Based on the data and other publications regarding the market size for newly discovered and effective treatment of CDI, ACXP believes Ibezapolstat could be a market worth over $1B. David explains how the Company will fund its FDA Phase 3 study and, upon successful approval, will leverage data/results for future approval(s) with the European Medicines Agency. Decades-old antibacterial drugs are not working due to changes in the molecular composition of CDI. Thousands of people worldwide die annually, with many catching CDI in hospitals and nursing homes. Acurx Pharmaceuticals, Inc. believes its Ibezapolstat drug is the next generation for effectively treating CDI. The on-screen QR code is available during the show; download or visit Acurx Pharmaceuticals, Inc. - https://www.acurxpharma.com/.

    New to The Street airs its "Game Changers Segment" with TV Host and Multi-media Journalist Ana Berry, who talks with Dr. Navjit Dhaliwal, CEO of IAGON (CRYPTO: IAG) (). IAGON is a "Game Changer" in the data compliance and storage industries with innovative decentralized blockchain technology solutions. Navjit talks about the global data breaches occurring in all industry types and how they happen. IAGON is a decentralized cloud storage solution with no single server holding data. "Big Tech" providers maintain a single server and a single file, so hackers steal clients' data when a cybersecurity breach occurs. IAGON is different; it slices data with multiple redundancies, is held on a secure and protected blockchain on numerous cloud servers. These location "Nodes" have several different data matrixes to meet clients' data storage and management needs. As a fully protected service, clients can choose performance options with locations in the USA, Norway, and elsewhere. IAGON blockchain data services improve users with operational sovereignty over data. With IAGON, data is in the client's control, no longer given to large "Big Tech" platforms without consent or fees. With layered encryption protocols, IAGON's decentralized blockchain data creates an ecosystem that can assist in many computer industries. AI, machine learning, and other technology platforms can benefit from adopting the IAGON platform. Navjit likens IAGON to Airbnb for data storage and management. With worldwide cybersecurity concerns magnified, all industries seek ways to protect themselves from data breaches. IAGON's decentralized blockchain data management ecosystem provides for multiple industries and uses, ensuring complete data protection, integrity, and efficiency. The on-screen QR code is available during the show; download or visit Iagon - https://iagon.com/.

    New to The Street's TV Host Jane King talks with Jason Cozens, CEO of Glint Pay, discussing how ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: GlobeX Data Ltd
    Stock Symbol: SWISF
    Market: OTC
    Website: globexdatagroup.com

    Menu

    SWISF SWISF Quote SWISF Short SWISF News SWISF Articles SWISF Message Board
    Get SWISF Alerts

    News, Short Squeeze, Breakout and More Instantly...